Eucrates Biomedical Statements
EU
Data from Eucrates Biomedical`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2022
Next reporting period:
29 Dec, 2022
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
—
Eucrates Biomedical Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
—
0
—
0
0.167
21.4 %
0
-0.167
-21.4 %
0
0.588
0
0.1
0
0.521
20.8 %
0
—
0
0.521
20.8 %
0
0.039
13.459
—
—
100
—
0
—
—
0
—
0
—
0
0.137
4.9 %
0
-0.137
-4.9 %
0
0.128
0
0.442
0
0.432
-67.4 %
0
—
0
0.432
-67.4 %
0
0.032
13.459
—
—
100
—
0
—
—
0
—
0
—
0
0.131
-43.9 %
0
-0.131
43.9 %
0
0.047
0
1.408
0
1.325
431.5 %
0
—
0
1.325
431.5 %
0
0.098
13.459
—
—
100
—
0
—
—
0
—
0
—
0
0.233
-10.2 %
0
-0.233
10.2 %
0
0.01
0
0.473
0
0.249
-73.8 %
0
—
0
0.249
-73.8 %
0
0.019
13.459
—
—
100
—
0
—
—
0
—
0
—
0
0.26
108.8 %
0
-0.26
-108.8 %
0
0.017
0
1.194
0
0.95
50.7 %
0
—
0
0.95
50.7 %
0
0.071
13.459
—
—
100
—
0
—
—
0
—
0
—
0
0.124
-0.7 %
0
-0.124
0.7 %
0
-0.005
0
0.76
0
0.631
-68.4 %
0
—
0
0.631
-68.4 %
0
0.047
13.459
—
—
100
—
0
—
—
0
—
0
—
0
0.125
-16.4 %
0
-0.125
16.4 %
0
0.016
0
2.104
0
1.994
1524.4 %
0
—
0
1.994
1524.4 %
0
0.148
13.459
—
—
100
—
0
—
—
0
—
0
—
0
0.15
4770.1 %
0
-0.15
-4770.1 %
0
0.01
0
—
0
-0.14
-4445.5 %
0
—
0
-0.14
-4445.5 %
0
-0.01
13.46
—
—
100
—
0
—
—
0
—
0
—
0
0.003
—
0
-0.003
—
0
—
0
—
0
-0.003
—
0
—
0
-0.003
—
0
0
13.459